A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma

Noa Biran; Eli Zolotov; David Vesole; Harsh Parmar; Pooja Phull; Kimberley Doucette; Patrick Roney; Jaeil Ahn; Rena Feinman; Joshua Zenreich; Palka Anand; Monique Pace; Alexandra Della Pia; Bianca DeAgresta; Lisa Biamonte; Adolfo Aleman; Ella Rutanen; Aimee Chappell; Susan Kumka; David S. Siegel

doi:10.3324/haematol.2024.287053

Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Letters to the Editor

A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma

Noa Biran
Eli Zolotov
David Vesole
Harsh Parmar
Pooja Phull
Kimberley Doucette
Patrick Roney
Jaeil Ahn
Rena Feinman
Joshua Zenreich
Palka Anand
Monique Pace
Alexandra Della Pia
Bianca DeAgresta
Lisa Biamonte
Adolfo Aleman
Ella Rutanen
Aimee Chappell
Susan Kumka
David S. Siegel

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ, USA; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ

Department of Internal Medicine, Hackensack University Medical Center, Hackensack, NJ

Georgetown University Medical Center, Washington, DC

Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, DC

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

Hackensack Meridian Health Center for Discovery and Innovation, Nutley, NJ

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

Georgetown University Medical Center, Washington, DC

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

Haematologica Early view Apr 3, 2025 https://doi.org/10.3324/haematol.2024.287053

Abstract

Not available.

Article Information

Early view : Letters to the Editor

DOI

https://doi.org/10.3324/haematol.2024.287053

Pubmed

40176757

Published

2025-04-03

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

376

PDF Downloads

174

A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma

Abstract

Figures & Tables

Article Information

Article Usage

Statistics from Altmetric.com

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More